(36B5) iShares MSCI EM SRI USD - Ratings and Ratios
ETF, Emerging Markets, Shares, ESG, Index
Description: 36B5 iShares MSCI EM SRI USD
The iShares MSCI EM SRI UCITS ETF USD (Dist) is an exchange-traded fund listed on XETRA, tracking the Morningstar EM TME NR USD index. It provides investors with exposure to emerging markets equities that meet certain sustainability and responsible investment criteria.
This ETF is designed for investors seeking to tap into the growth potential of emerging markets while adhering to socially responsible investing principles. The funds underlying index is constructed to reflect the performance of companies in emerging markets that demonstrate strong environmental, social, and governance (ESG) characteristics.
Analyzing the ETFs recent price action, we observe a bullish trend, as indicated by the short-term and long-term moving averages. The SMA20 and SMA50 are both trending upwards, with the SMA20 at 4.87 and SMA50 at 4.65, suggesting a positive momentum. Furthermore, the SMA200 at 4.82 indicates that the ETF is currently trading above its long-term average, reinforcing the bullish sentiment.
Given the current ATR of 0.06, representing a 1.17% daily price movement, and considering the 52-week high and low of 5.12 and 4.07, respectively, we can infer that the ETF is experiencing moderate volatility. The current price of 4.97 is near the upper end of its recent trading range, suggesting potential for further upside.
With an AUM of 3597.45M EUR, the fund has a substantial asset base, indicating a certain level of investor confidence and liquidity. This, combined with its tracking of a reputable index, makes it an attractive option for investors seeking diversified exposure to emerging markets with a focus on ESG.
Forecasting future performance based on the available technical and fundamental data, we can anticipate that the ETF may continue its upward trend, driven by the positive momentum indicated by its moving averages. However, the moderate volatility, as suggested by the ATR, necessitates a cautious approach. A potential target price could be around 5.20, assuming a continuation of the current trend and a slight expansion of its trading range. Conversely, a decline below the SMA50 at 4.65 could signal a reversal in the trend, warranting a re-evaluation of the investment thesis.
Additional Sources for 36B5 ETF
36B5 ETF Overview
Market Cap in USD | 367m |
Category | Global Emerging Markets Equity |
TER | 0.25% |
IPO / Inception | 2018-12-06 |
36B5 ETF Ratings
Growth Rating | 10.9 |
Fundamental | - |
Dividend Rating | 48.4 |
Rel. Strength | -15.1 |
Analysts | - |
Fair Price Momentum | 5.34 EUR |
Fair Price DCF | - |
36B5 Dividends
Dividend Yield 12m | 2.23% |
Yield on Cost 5y | 2.85% |
Annual Growth 5y | 4.78% |
Payout Consistency | 94.0% |
Payout Ratio | % |
36B5 Growth Ratios
Growth Correlation 3m | 91.9% |
Growth Correlation 12m | 18.9% |
Growth Correlation 5y | -15.2% |
CAGR 5y | 5.52% |
CAGR/Max DD 5y | 0.22 |
Sharpe Ratio 12m | -0.09 |
Alpha | 1.71 |
Beta | 0.645 |
Volatility | 13.70% |
Current Volume | 65.1k |
Average Volume 20d | 31.8k |
Stop Loss | 4.9 (-3.9%) |
As of July 18, 2025, the stock is trading at EUR 5.10 with a total of 65,084 shares traded.
Over the past week, the price has changed by +2.38%, over one month by +4.75%, over three months by +19.45% and over the past year by +11.60%.
Neither. Based on ValueRay´s Analyses, iShares MSCI EM SRI USD is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 10.87 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of 36B5 is around 5.34 EUR . This means that 36B5 is currently overvalued and has a potential downside of 4.71%.
iShares MSCI EM SRI USD has no consensus analysts rating.
According to our own proprietary Forecast Model, 36B5 iShares MSCI EM SRI USD will be worth about 6.1 in July 2026. The stock is currently trading at 5.10. This means that the stock has a potential upside of +18.63%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 6.1 | 18.6% |